Moneycontrol PRO

business

Exports to US will continue normally post audit: Dishman Pharma

Two minor observations pertaining to a 2014 audit were reported by the US FDA in its recent inspection, says JR Vyas, CMD of Dishman Pharma.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark